MB "Kineziterapijos namai" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 7,185 |
| - |
| -1,120 |
| -1,120 |
| - |
| 100.00 |
| -15.59 |
| 3,654 |
| 26 |
| 0 |
| 3,680 |
| 0.51 |
| 0.01 |
| - |
| - |
| -15.59 |
| -1,120 |
| 2023 |
|---|
| 9,381 |
| - |
| -791 |
| -791 |
| - |
| 100.00 |
| -8.43 |
| 2,863 |
| 270 |
| 0 |
| 3,133 |
| 0.31 |
| 0.09 |
| - |
| - |
| -8.43 |
| -791 |
| 2024 |
|---|
| 9,435 |
| - |
| -48 |
| -48 |
| - |
| 100.00 |
| -0.51 |
| 2,815 |
| 83 |
| 0 |
| 2,898 |
| 0.30 |
| 0.03 |
| - |
| - |
| -0.51 |
| -48 |
| 2024 |
|---|
| 9,435 |
| - |
| -48 |
| -48 |
| - |
| 100.00 |
| -0.51 |
| 2,815 |
| 83 |
| 0 |
| 2,898 |
| 0.30 |
| 0.03 |
| - |
| - |
| -0.51 |
| -48 |
Turnover (€)
2024
Turnover (€)
9,435 €1 % *
Sales per employee (€)
-Profit before tax (€)
-48 €94 % *
Net Profit (€)
-48 €94 % *
Profit per employee (€)
-Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
-0.51 %93.95 % *
Equity (€)
2,815 €-2 % *
Amounts Payable And Liabilities (€)
83 €-69 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
2,898 €-8 % *
Working capital requirement
0.30 -3.23 % *
Debt-to-equity ratio
0.03 -66.67 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-0.51 %93.95 % *
EBIT (€)
-48 €94 % *
